Skip to Content

M 714 (Risedronate Sodium 35 mg)

Pill with imprint M 714 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Mylan Pharmaceuticals Inc..

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 714

Risedronate sodium 35 mg M 714 Front
Risedronate sodium 35 mg M 714 Back
Risedronate sodium 35 mg M 714
Risedronate sodium 35 mg M 714

Risedronate Sodium

Imprint
M 714
Strength
35 mg
Color
Orange
Shape
Round
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4714

Get help with Imprint Code FAQs.

Related Images for "M 714"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.